Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of Quest Diagnostics, Inc (NYSE: DGX) closed at $168.37 in the last session, up 0.17% from day before closing price of $168.09. In other words, the price has increased by $0.17 from its previous closing price. On the day, 1.27 million shares were traded. DGX stock price reached its highest trading level at $169.28 during the session, while it also had its lowest trading level at $166.875.
Ratios:
We take a closer look at DGX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 99.98 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.80. For the most recent quarter (mrq), Quick Ratio is recorded 1.31 and its Current Ratio is at 1.44. In the meantime, Its Debt-to-Equity ratio is 0.95 whereas as Long-Term Debt/Eq ratio is at 0.92.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Redburn Atlantic on April 02, 2025, initiated with a Buy rating and assigned the stock a target price of $195.
On March 04, 2025, Citigroup Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $185.
Leerink Partners Upgraded its Market Perform to Outperform on January 06, 2025, whereas the target price for the stock was revised from $169 to $174.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 12 ’25 when DELANEY MARK E sold 874 shares for $175.72 per share. The transaction valued at 153,579 led to the insider holds 8,372 shares of the business.
DELANEY MARK E sold 874 shares of DGX for $153,221 on May 13 ’25. The SVP & Chief Commercial Officer now owns 7,498 shares after completing the transaction at $175.31 per share. On May 13 ’25, another insider, DELANEY MARK E, who serves as the Officer of the company, bought 874 shares for $175.31 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DGX now has a Market Capitalization of 18795984896 and an Enterprise Value of 26555080704. As of this moment, Quest’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.28, and their Forward P/E ratio for the next fiscal year is 16.06. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.60. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.85 while its Price-to-Book (P/B) ratio in mrq is 2.72. Its current Enterprise Value per Revenue stands at 2.614 whereas that against EBITDA is 13.446.
Stock Price History:
The Beta on a monthly basis for DGX is 0.47, which has changed by 0.13304174 over the last 52 weeks, in comparison to a change of 0.10611236 over the same period for the S&P500. Over the past 52 weeks, DGX has reached a high of $182.38, while it has fallen to a 52-week low of $137.71. The 50-Day Moving Average of the stock is -4.19%, while the 200-Day Moving Average is calculated to be 2.32%.
Shares Statistics:
According to the various share statistics, DGX traded on average about 1.09M shares per day over the past 3-months and 931690 shares per day over the past 10 days. A total of 112.00M shares are outstanding, with a floating share count of 111.01M. Insiders hold about 0.56% of the company’s shares, while institutions hold 94.44% stake in the company. Shares short for DGX as of 1749772800 were 3639500 with a Short Ratio of 4.56, compared to 1747267200 on 3899358. Therefore, it implies a Short% of Shares Outstanding of 3639500 and a Short% of Float of 3.7199999999999998.
Dividends & Splits
The forward annual dividend rate for DGX is 3.10, which was 3.05 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.018145042The stock’s 5-year Average Dividend Yield is 1.87. The current Payout Ratio is 39.15% for DGX, which recently paid a dividend on 2025-07-07 with an ex-dividend date of 1751846400. Stock splits for the company last occurred on 2005-06-21 when the company split stock in a 2:1 ratio.
Earnings Estimates
The market rating of Quest Diagnostics, Inc (DGX) is currently shaped by the ongoing analysis conducted by 14.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $2.51, with high estimates of $2.53 and low estimates of $2.48.
Analysts are recommending an EPS of between $9.76 and $9.65 for the fiscal current year, implying an average EPS of $9.7. EPS for the following year is $10.53, with 17.0 analysts recommending between $10.82 and $10.3.
Revenue Estimates
According to 12 analysts, the current quarter’s revenue is expected to be $2.73B. It ranges from a high estimate of $2.79B to a low estimate of $2.7B. As of the current estimate, Quest Diagnostics, Inc’s year-ago sales were $2.4BFor the next quarter, 12 analysts are estimating revenue of $2.71B. There is a high estimate of $2.73B for the next quarter, whereas the lowest estimate is $2.69B.
A total of 17 analysts have provided revenue estimates for DGX’s current fiscal year. The highest revenue estimate was $10.85B, while the lowest revenue estimate was $10.77B, resulting in an average revenue estimate of $10.79B. In the same quarter a year ago, actual revenue was $9.87BBased on 17 analysts’ estimates, the company’s revenue will be $11.23B in the next fiscal year. The high estimate is $11.46B and the low estimate is $11.1B.
